Sales & Marketing
HCPs, DOLs
Sponsored

Local voices, global reach

Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.

Articles
Demand grows for cancer R&D executives

Demand grows for cancer R&D executives

The recent acquisition of Norway's biotech frontrunner, Algeta, by Bayer for $2.9 billion, purchasing their exciting new prostate cancer drug Xofigo, has brought considerable attention on Oslo,

Articles
How pharma can generate ROI on social media

How pharma can generate ROI on social media

For companies in the pharma sector, LinkedIn represents a vastly under-used opportunity to conduct business and generate that elusive return-on-investment online.

Articles
Customer complexity in pharma marketing

Customer complexity in pharma marketing

In the new and 'still forming' NHS, one thing is clear: the pharma industry's customers are increasingly complex with a blurring of lines between clinician and payer, and growing patient power.

Sales & Marketing

Sales & Marketing
HCPs, DOLs
Sponsored

Local voices, global reach

Digital Opinion Leaders with regional followings are shaping prescribing behaviour in ways that international Key Opinion Leaders are not.

Digital

Market Access

Editor's Picks

  1. Novartis halts CAR-T trials after patient deaths
  2. White House signs pricing deals with nine more pharmas
  3. Enhertu OK ends 10-year EU gap in frontline breast cancer
  4. Roche taps Simcere for autoimmune trispecific for $1.53bn
  5. Hutchmed rises on $1.3bn KRAS licensing deal with GSK

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

more

Patients

more

R&D

more